A game-changer for women’s health! The Indian government will soon roll out a nationwide free HPV vaccination programme targeting 14-year-old girls to eliminate cervical cancer. Using a single dose of Gardasil vaccine, this special campaign promises lifelong protection against HPV types 16, 18, 6, and 11, the primary culprits behind nearly all cervical cancer cases in India.
Cervical Cancer Crisis in India
Cervical cancer ranks as India’s second most common cancer among women, claiming over 42,000 lives yearly from 80,000 new cases. HPV infection causes virtually all cases, with types 16 and 18 responsible for 80%+. Vaccination at age 14, before exposure, offers maximum prevention, aligning with WHO’s global cervical cancer elimination strategy.
If you enjoyed reading this article, you can help support our journalism by adding OHeraldo as a preferred source.
Single-Shot Gardasil: Proven Protection
Gardasil, manufactured by MSD India, delivers robust immunity with one dose for girls under 15. Global data shows 93-100% effectiveness against vaccine-covered HPV strains. Over 500 million doses administered worldwide since 2006 confirm excellent safety. India joins 160 countries with HPV programmes, 90 using single-dose schedules.
Voluntary, Free, and Accessible
The voluntary drive operates outside Universal Immunisation at Ayushman Arogya Mandirs and government facilities with 24/7 support. Unlike market prices (₹3,927 per dose), this ensures equity across socio-economic groups. Officials hail it as a “Swastha Nari” milestone, slashing future cancer burden through early prevention.
Global Success, Indian Future
Countries with HPV vaccination saw dramatic drops in infections, precancerous lesions, and cervical cancer. India’s campaign positions the nation for similar gains, safeguarding generations.
(This story has been published from a syndicated feed)
